Effect of exogenous leptin on intestinal mucosal proliferation in rats with obstructive jaundice

doi:10.3877/cma.j.issn.1674-0785.2023.05.013

Abstract

Abstract:

Objective

To explore the effect of exogenous leptin on the proliferation of the intestinal mucosa in rats with obstructive jaundice.

Methods

Obstructive jaundice was induced by surgery in 32 Wistar rats, which were then randomly divided into either a control group or a study group, with 16 rats in each group. The study group was given recombinant leptin (10 μg/kg, bid) by intraperitoneal injection after operation, while the control group was injected with equal volume of saline. Rats in each group were sacrificed at 5 days and 8 days, and then labeled as C5 group, C8 group, S5 group, and S8 group, respectively. The general conditions of the rats were observed. Intestinal mucosal tissues were stained with hematoxylin-eosin (HE), and the changes of intestinal mucosal morphology and damage were observed. Immunohistochemistry (IHC) was used to detect the expression of leptin, leptin receptor, and Ki67 in the intestinal mucosa.

Results

The intestinal mucosal injury index was significantly lower in the control group than in the study group, while it was significantly higher in the C5 and S5 groups than in the C8 and S8 groups. The expression of leptin and leptin receptor in the control group was significantly lower than that in the study group, while it was significantly higher in the C5 and S5 groups than that in the C8 and S8 groups, respectively.

Conclusion

Exogenous leptin has the effect of promoting the proliferation and mitigate the damage of intestinal mucosal cells in rats with obstructive jaundice.

Key words: Leptin, Obstructive jaundice, Intestinal mucosa, Proliferation

Hui Fang, Fei Li, Fan Zhang, Qiang Wei, Qiangpu Chen. Effect of exogenous leptin on intestinal mucosal proliferation in rats with obstructive jaundice[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(05): 575-580.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2023.05.013

https://zhlcyszz.cma-cmc.com.cn/EN/Y2023/V17/I05/575

Figures/Tables 9

References 25

1	Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue [J]. Nature, 1994, 372(6505): 425-432.
2	Zhang Y, Chua SJr. Leptin Function and Regulation [J]. Compr Physiol, 2017, 8(1): 351-369.
3	方辉, 陈强谱. 瘦素与胃肠功能的维护 [J]. 世界华人消化杂志, 2015, 23(18): 2920-2927.
4	郭松, 陈强谱, 林旭涛, 等. 梗阻性黄疸患者肠黏膜瘦素及其受体与肠黏膜免疫屏障损害的关系 [J/OL]. 中华普通外科学文献(电子版), 2015, 9(2): 103-107.
5	Şimşek T, Ersoy ÖF, Özsoy Z, et al. Effect of sildenafil citrate on the liver structure and function in obstructive jaundice: An experimental study [J]. Turk J Surg, 2018, 34(2): 111-116.
6	方辉, 陈强谱, 张兴元, 等. 可复性梗阻性黄疸大鼠模型的建立与评价 [J]. 世界华人消化杂志, 2015, 23(25): 4015-4023.
7	Pavlidis ET, Pavlidis TE. Pathophysiological consequences of obstructive jaundice and perioperative management [J]. Hepatobiliary Pancreat Dis Int, 2018, 17(1): 17-21.
8	Yang R, Zhu S, Pischke SE, et al. Bile and circulating HMGB1 contributes to systemic inflammation in obstructive jaundice [J]. J Surg Res, 2018, 228: 14-19.
9	Shao C, Li Y, Chen J, et al. Physical Exercise Repairs Obstructive Jaundice-Induced Damage to Intestinal Mucosal Barrier Function via H2S-Mediated Regulation of the HMGB1/Toll Like Receptors 4/Nuclear Factor Kappa B Pathway [J]. Front Physiol, 2022, 12: 732780.
10	Zhang CX, Shu CM, Zhang XY, et al. Effect and mechanism of omega-3 polyunsaturated fatty acids on intestinal injury in rats with obstructive jaundice [J]. Eur Rev Med Pharmacol Sci, 2021, 25(19): 6077-6092.
11	D'souza AM, Neumann UH, Glavas MM, et al. The glucoregulatory actions of leptin [J]. Mol Metab, 2017, 6(9): 1052-1065.
12	Xie D, Bollag WB. Obesity, hypertension and aldosterone: is leptin the link? [J]. J Endocrinol, 2016, 230(1): F7-F11.
13	Liu J, Yang X, Yu S, et al. The Leptin Signaling [J]. Adv Exp Med Biol, 2018, 1090: 123-144.
14	Azamar-Llamas D, Hernández-Molina G, Ramos-Ávalos B, et al. Adipokine Contribution to the Pathogenesis of Osteoarthritis [J]. Mediators Inflamm, 2017, 2017: 5468023.
15	凌伟, 于红刚. 瘦素受体基因多态性与消化道肿瘤研究进展 [J]. 武汉大学学报(医学版), 2018, 39(1): 163-167.
16	Scotece M, Pérez T, Conde J, et al. Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient [J]. J Orthop Res, 2017, 35(6): 1299-1303.
17	Abella V, Scotece M, Conde J, et al. Leptin in the interplay of inflammation, metabolism and immune system disorders [J]. Nat Rev Rheumatol, 2017, 13(2): 100-109.
18	Wasim M, Awan FR, Najam SS, et al. Role of leptin deficiency, inefficiency, and leptin receptors in obesity [J]. Biochem Genet, 2016, 54(5): 565-572.
19	Barnes MA, Carson MJ, Nair MG. Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system [J]. Cytokine, 2015, 72(2): 210-219.
20	Wei L, Chen Y, Zhang C, et al. Leptin induces IL-6 and IL-8 expression through leptin receptor Ob-Rb in human dental pulp fibroblasts [J]. Acta Odontol Scand, 2019, 77(3): 205-212.
21	Pérez-Pérez A, Vilariño-García T, Fernández-Riejos P, et al. Role of leptin as a link between metabolism and the immune system [J]. Cytokine Growth Factor Rev, 2017, 35: 71-84.
22	Margiotta D, Navarini L, Vadacca M, et al. Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results [J]. Eur Rev Med Pharmacol Sci, 2016, 20(4): 636-641.
23	Carmona-Maurici J, Cuello E, Ricart-Jané D, et al. Effect of bariatric surgery on inflammation and endothelial dysfunction as processes underlying subclinical atherosclerosis in morbid obesity [J]. Surg Obes Relat Dis, 2020, 16(12): 1961-1970.
24	Srinivasan G, Parida S, Pavithra S, et al. Leptin receptor stimulation in late pregnant mouse uterine tissue inhibits spontaneous contractions by increasing NO and cGMP [J]. Cytokine, 2021, 137: 155341.
25	Kang DR, Yadav D, Koh SB, et al. Impact of serum leptin to adiponectin ratio on regression of metabolic syndrome in high-risk individuals: The Arirang study [J]. Yonsei Med J, 2017, 58(2): 339-346.

组别	C组	S组	F值	P值
5 d	528.89±226.71	577.26±169.71^a	4.772	=0.01
8 d	486.94±192.52	494.57±88.32^a	61.971	＜0.01

组别	C组	S组	F值	P值
5 d	528.89±226.71	577.26±169.71^a	4.772	=0.01
8 d	486.94±192.52	494.57±88.32^a	61.971	＜0.01

分组	C组	S组	F值	P值
5 d	198.23±70.26	236.89±46.22^a	14.760	=0.01
8 d	186.3±105.87	242.17±85.77^a	22.188	＜0.01

分组	C组	S组	F值	P值
5 d	198.23±70.26	236.89±46.22^a	14.760	=0.01
8 d	186.3±105.87	242.17±85.77^a	22.188	＜0.01

组别	C组	S组	F值	P值
5 d	0.0815±0.0310	0.1340±0.0418^a	4.596	＜0.05
8 d	0.0791±0.0238	0.1252±0.0188^a	8.635	＜0.01

Please choose a citation manager

Content to export